DBV Technologies company profile

DBV · Euronext Paris · EUR

Compare DBV Technologies
€1.66Change from previous close: −6.64%Absolute change: −€0.12

Close · November 20, 2026

Company profile

DBV Technologies has 179 employees and is headquartered in Châtillon, France.

Viaskin Peanut, an epicutaneous immunotherapy product for peanut allergy, has completed a Phase 3 clinical trial, while Viaskin Milk, aimed at cow's milk protein allergy and eosinophilic esophagitis, is in Phase 1/2 trials. The company also runs earlier-stage research into celiac disease and develops the Viaskin technology platform, which is designed to potentially treat food allergy. Its collaboration with Nestlé Health Science covers MAG1C, a ready-to-use atopy patch test for diagnosing non-IgE mediated cow's milk protein allergy in infants and toddlers.

In the fiscal year ended December 2025, DBV Technologies reported revenue of USD 5.6 million, up 35.8% on the previous year, and a net loss of USD 146.9 million. Its research and development is carried out in France. The company had 179 employees and is headquartered in Châtillon, France; it was incorporated in 2002.

Company facts

Industry
Biotechnology
Country
France
Headquarters
BAtiment IRO, 92320, Châtillon
Employees
179
Chief executive
Daniel Tassé
Founded
2002
Fiscal year
January - December
Listing
DBV · Euronext Paris
Currency
EUR
ISIN
FR0010417345

DBV Technologies and its competitors

The most similar companies by business and size

CompanyCountryMarket capEmployeesOperating marginP/E (trailing 12 months)
DBV TechnologiesDBVFrance$572.52M179-5,577.0%—
GubraGUBRADenmark$730.02M330-73.1%—
Pharming GroupPHARMNetherlands$841.25M40712.8%36.1
InventivaIVAFrance$890.8M87-5,980.9%—
PhilogenPHILItaly$905.96M23079.1%3.67
Basilea PharmaceuticaBSLNSwitzerland$1.07B20024.2%18.1

Competitors: same or related industry, same region first, then the closest market capitalization. Market cap converted into US dollars at the latest exchange rates; P/E over the last 12 months, not shown when negative.

Compare DBV Technologies with its competitors